Copyright Reports & Markets. All rights reserved.

Global Alzheimer’s Therapeutic Market Research Report 2019

Buy now

Table of Contents

    Global Alzheimer’s Therapeutic Market Research Report 2018

      1 Alzheimer’s Therapeutic Market Overview

      • 1.1 Product Overview and Scope of Alzheimer’s Therapeutic
      • 1.2 Alzheimer’s Therapeutic Segment by Type (Product Category)
        • 1.2.1 Global Alzheimer’s Therapeutic Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Alzheimer’s Therapeutic Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Memantine Hydrochloride
        • 1.2.3 Donepezil Hydrochloride
        • 1.2.5 Rivastigmine

      Galantamine Hydrobromide

      • 1.3 Global Alzheimer’s Therapeutic Segment by Application
        • 1.3.1 Alzheimer’s Therapeutic Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinic
        • 1.3.4 Other
      • 1.4 Global Alzheimer’s Therapeutic Market by Region (2013-2025)
        • 1.4.1 Global Alzheimer’s Therapeutic Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Alzheimer’s Therapeutic (2013-2025)
        • 1.5.1 Global Alzheimer’s Therapeutic Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Alzheimer’s Therapeutic Capacity, Production Status and Outlook (2013-2025)

      2 Global Alzheimer’s Therapeutic Market Competition by Manufacturers

      • 2.1 Global Alzheimer’s Therapeutic Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Alzheimer’s Therapeutic Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Alzheimer’s Therapeutic Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Alzheimer’s Therapeutic Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Alzheimer’s Therapeutic Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Alzheimer’s Therapeutic Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Alzheimer’s Therapeutic Market Competitive Situation and Trends
        • 2.5.1 Alzheimer’s Therapeutic Market Concentration Rate
        • 2.5.2 Alzheimer’s Therapeutic Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Alzheimer’s Therapeutic Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Alzheimer’s Therapeutic Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Alzheimer’s Therapeutic Production and Market Share by Region (2013-2018)
      • 3.3 Global Alzheimer’s Therapeutic Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Alzheimer’s Therapeutic Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Alzheimer’s Therapeutic Consumption by Region (2013-2018)
      • 4.2 North America Alzheimer’s Therapeutic Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Alzheimer’s Therapeutic Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Alzheimer’s Therapeutic Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Alzheimer’s Therapeutic Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Alzheimer’s Therapeutic Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Alzheimer’s Therapeutic Production, Consumption, Export, Import (2013-2018)

      5 Global Alzheimer’s Therapeutic Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Alzheimer’s Therapeutic Production and Market Share by Type (2013-2018)
      • 5.2 Global Alzheimer’s Therapeutic Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Alzheimer’s Therapeutic Price by Type (2013-2018)
      • 5.4 Global Alzheimer’s Therapeutic Production Growth by Type (2013-2018)

      6 Global Alzheimer’s Therapeutic Market Analysis by Application

      • 6.1 Global Alzheimer’s Therapeutic Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Alzheimer’s Therapeutic Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Alzheimer’s Therapeutic Manufacturers Profiles/Analysis

      • 7.1 Pfizer Inc
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Pfizer Inc Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Novartis International AG
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Novartis International AG Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Axovant Sciences Ltd
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Axovant Sciences Ltd Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Acadia Pharmaceuticals, Inc
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Biotie Therapies
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Biotie Therapies Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 Astra Zeneca plc
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 Astra Zeneca plc Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 Eli Lilly, Inc
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 Eli Lilly, Inc Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview
      • 7.8 F. Hoffman Le Roche
        • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.8.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.8.2.1 Product A
          • 7.8.2.2 Product B
        • 7.8.3 F. Hoffman Le Roche Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.8.4 Main Business/Business Overview
      • 7.9 Merck & Co
        • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.9.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.9.2.1 Product A
          • 7.9.2.2 Product B
        • 7.9.3 Merck & Co Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.9.4 Main Business/Business Overview
      • 7.8 H. Lundbeck A/S
        • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.10.2 Alzheimer’s Therapeutic Product Category, Application and Specification
          • 7.10.2.1 Product A
          • 7.10.2.2 Product B
        • 7.10.3 H. Lundbeck A/S Alzheimer’s Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.10.4 Main Business/Business Overview
      • 7.11 Takeda Pharmaceutical Company Ltd

      8 Alzheimer’s Therapeutic Manufacturing Cost Analysis

      • 8.1 Alzheimer’s Therapeutic Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Alzheimer’s Therapeutic

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Alzheimer’s Therapeutic Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Alzheimer’s Therapeutic Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Alzheimer’s Therapeutic Market Forecast (2018-2025)

      • 12.1 Global Alzheimer’s Therapeutic Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Alzheimer’s Therapeutic Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Alzheimer’s Therapeutic Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Alzheimer’s Therapeutic Price and Trend Forecast (2018-2025)
      • 12.2 Global Alzheimer’s Therapeutic Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Alzheimer’s Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Alzheimer’s Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Alzheimer’s Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Alzheimer’s Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Alzheimer’s Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Alzheimer’s Therapeutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Alzheimer’s Therapeutic Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Alzheimer’s Therapeutic Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        This report studies the global Alzheimer’s Therapeutic market status and forecast, categorizes the global Alzheimer’s Therapeutic market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

        The major manufacturers covered in this report
        Pfizer Inc
        Novartis International AG
        Axovant Sciences Ltd
        Acadia Pharmaceuticals, Inc
        Biotie Therapies
        Astra Zeneca plc
        Eli Lilly, Inc
        F. Hoffman Le Roche
        Merck & Co
        H. Lundbeck A/S
        Takeda Pharmaceutical Company Ltd

        Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Memantine Hydrochloride
        Donepezil Hydrochloride
        Rivastigmine
        Galantamine Hydrobromide
        On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
        Hospitals
        Clinic
        Other

        The study objectives of this report are:
        To analyze and study the global Alzheimer’s Therapeutic capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
        Focuses on the key Alzheimer’s Therapeutic manufacturers, to study the capacity, production, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Alzheimer’s Therapeutic are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        Alzheimer’s Therapeutic Manufacturers
        Alzheimer’s Therapeutic Distributors/Traders/Wholesalers
        Alzheimer’s Therapeutic Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the Alzheimer’s Therapeutic market, by end-use.
        Detailed analysis and profiles of additional market players.

        Buy now